Purple Biotech Ltd. (PPBT)
Nasdaq: PPBT · Pharmaceutical Preparations · Rehovot, IL · filing with the SEC since 2014
Who owns Purple Biotech Ltd.
As filed with the SECHolders of 5% or more
2
Mitchell P. Kopin holds 9.99% of Ordinary shares, no par value per share, as its SCHEDULE 13G/A filed May 13, 2026 says.
Directors and officers
7
report now, of 7 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Mitchell P. Kopin
SCHEDULE 13G/A · filed May 13, 2026 · Ordinary shares, no par value per share · 9.99% in Nov 7, 2025
Lincoln Alternative Strategies LLC
SCHEDULE 13G · filed Sep 9, 2025 · American Depositary Shares, each representing 200 Ordinary Shares
Orca Capital AG
SCHEDULE 13G/A · filed Sep 9, 2025 · American Depositary Shares, each representing 200 Ordinary Shares · reported falling below 5%, from 9.9% in Sep 9, 2025
G1 Execution Services, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Ordinary Shares, no par value per share · reported falling below 5%, from 5.2% in Feb 13, 2026
What PPBT reports owning in othersstakes of 5% or more, and other ties
4 subsidiaries in 2 countries, from the list filed with the 20-F filed Mar 10, 2025.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.